Upregulation of FLT1 activates the TGF-β1/Smad3 pathway to promote iodide resistance in thyroid cancer
{{output}}
Background: The identification of new therapeutic targets for patients with radioiodide resistance differentiated thyroid cancer (DTC) may help improve the prognosis for I131-resistant DTC patients. ... ...
